Surf Air, a company that brings you above the clouds. Being a member of this innovative airline allows for a luxurious private charter without the chaotic, disorganized, and time-consuming headache that coincides with traditional airlines. With only a few other likeminded individuals enjoying the extravagance and freedom of flight with you at a time, there’s no need to be stressed about air travel again. Surf Air allows you to choose from a list of scheduled times to an unlimited amount of flights, experience a thirty second booking process, and keeps expenses at a minimum.
In an article recently published at PR Newswire, Surf Air celebrates five years of enhancing air travel and offering membership upgrades and enhancements. So how did this company develop? In the beginning, Surf Air created a partnership with All Roads North, which has been providing luxury road travel. As Surf Air has grown and planned different expansion options, another partnership has been created with a similar company, The Private Suite LAX to help in expanding their membership network. Following this partnership another one was formed with FoundersCard, a community of thousands of innovators that are granted benefits (elite status, priority check in, as well as a variety of savings); networking opportunities are also immense with this partner. These different branches that have combined with Surf Air show just how much promise this company holds.
There are different membership levels and Surf Air’s preferred and premium members get to receive a complimentary annual membership as well as preferred rates to a new terminal at LAX. What’s more; this company offers no lines, private TSA screening and customs is taken care of on site; saving valuable time for their members. Another advantage that members receive are private suites, food, and a view of the runway. Airports typically drain energy and take quite a bit of time away from planned trips, Surf Air has found a way to fix common airline problems and making the travel experience memorable and enjoyable. Innovation at its finest.
Sheldon Lavin is a man in his ripe years, born over eight decades ago precisely in 1932, his success story has been one to reckon with in the food industry across America. He prides himself on being an outstanding graduate of the University of Illinois where he emerged with a degree in Accounting. Years later, he was incorporated into the Northwestern University with his primary focus on Finance. To mark the end in his quest for education, Sheldon emerged with a Bachelors degree in Business from the prestigious Roosevelt University situated in the outskirts of Chicago, Illinois. Armed with the excellent knowledge he had extensively gained over the period, Sheldon Lavin set out on a journey to cement his ground in the vast industry by establishing his own company, Sheldon Lavin & Associates, a financial consulting firm with its base in Chicago. He focused on the growth of this firm for a period spanning fifteen years.
The excellent skills he showcased in engaging other firms that ran after his services laid the foundation on which he would join one of the food processing heavyweights in America. The year 1970 marked a significant transformation as Sheldon Lavin was absorbed into the OSI Group Industries, a food processing line whose operations span across 18 countries. His experience brought in a new taste in the industry as he engaged the company in game-changing transformations that have seen it grow tremendously over the years. From a mere butchery to a gigantic food processor, the OSI Industries owe their skyrocketing expansion to the unequivocal expertise showcased by Lavin. Under his able stewardship, the OSI Group Industries net worth has been on full throttle over the years.
This is in a considerable way attributed to the technological advancements at the company. This has enabled the firm to double its production of chicken from the previous 12,000 tons a year. The expansion in production plants has mushroomed job opportunities for locals as the group seeks to sustain the ever-rising demand for their products, a move which has enabled them to receive funds from the European Agricultural Guarantee Fund. The funds will aid in their further expansion across Spain in a bid to create employment opportunities for her people. Sheldon Lavin has scooped several awards owing to his exemplary skills in managing the operations of the food processing line. Due to the numerous charity events that he sponsored, he was awarded the Edward C. Jones Community award in 2016, and the Global Visionary Award later in the same year.
Those who are making investments of any kind need to know what they are doing and which investments will work out the best for them financially. The Oxford Club is there for those people who are getting started investing and this group can support such people and lead them to make solid investments. There are three different levels of membership with this club and each person has to figure out which one is the right one for them. An introductory level of the club is the Premier Membership. This is a membership given to anyone who subscribes to publications from the club. The middle level of the club is the Director’s Circle. This level gives investors access to the club’s newsletters among other things. The highest level of membership when it comes to the Oxford Club is the Chairman’s Circle Membership. This level gives a person access to a lifetime’s subscription of publications from the club as well as other special features.
The Oxford Club is a private club made up of individuals who are knowledgeable about investing. Those who are a part of this club are working to grow their wealth and to create better futures for themselves. This club is a selective one and it is particular about those it will allow in, but it is not a secretive club in any way. It is well known and respected.
The Oxford Club helps its members by looking into the various investment opportunities that they come across and figuring out which are sound investment options. They share the best opportunities with those who are a part of the club. The Oxford Club has been around for more than two decades, and it has educated many individuals through the years. It helps those who are making investments do that in a smart way.
JeanMarie Guenot, Ph.D., has an impressive career spanning more than 20 years and involving both business and science specialties. Dr. Guenot’s leadership helps build companies in biotechnology and pharmaceutical industries. Her scientific accomplishments include the discovery and development of medicines used to treat a range of conditions, especially cancer. Several companies have gained advantages from partnering with Dr. Guenot by garnering substantial financial strength or making strides in pharmaceutical development.
According to Dr. Guenot’s biography, posted on her official website, she began her business pursuits at a venture capital firm specializing in life science companies. She assisted with early stage financing for start-ups in the field and managed venture capital investments for the firm. From there, Dr. Guenot excelled at a range of business development tasks starting with venture capital procurement, then assisting with project and corporate development, allegiance creation and pharmaceutical research advancement. One of her outstanding achievements is the collaboration that brought together three drug candidates in an $8 million transaction. Dr. Guenot also created her own start-up incubator, SKS Ocular, for ophthalmic companies devoted to finding treatments and treatment methods for glaucoma, macular degeneration and other ocular concerns. Her success has enabled Dr. JeanMarie Guenot to receive both the BioBusiness Network’s Innovative Bio-Partnering Award and the Licensing Executives Society’s Deal of Distinction Award.
Dr. Guenot was president and chief executive officer of the drug development company, Amphivena Therapeutics when Amphivena partnered with Janssen Biotech, Inc. in 2015. The companies planned to develop new treatments for hematologic malignancies, or blood cancers, such as leukemia. An article in Marketwired dated April 7, 2015, states the partnership yielded results earlier than expected. This collaboration is only one example of how entities associated with Dr. JeanMarie Guenot have assisted partners in the development of innovative oncology, autoimmune disease, inflammation, cardiovascular disease and other therapies and treatments. Dr. Guenot’s career path is backed by her education as she earned an MBA from the University of Pennsylvania’s Wharton School, followed by a Ph.D. from the University of California thus equipping her with the knowledge she needed to excel not only in business development but also the biotechnology industry.
Kyle Bass is the founder of Hayman Capital Management located in Dallas. His company is a hedge fund focusing on global opportunities. After he launched this hedge fund, he became big in the financial services industry because he successfully predicted information about the mortgage crisis.
Concerns are raised about hedge funds because they pose a challenge to drug patents that intend to gain money by purposefully dragging stock market prices down. Kyle Bass tried to eliminate drug patents; he says that larger companies try to extend the patent by changing the dosage or packaging, and in turn this keeps the drug prices high. This makes it extremely hard for the consumer to get their medications.
As time went on, Kyle Bass has made multiple negative career choices that made his untrustworthy. The more he puts himself on the media, the more his performance quality decreases. Bass tends to side with those who do not know what they are doing with their economic investments. He also tried to shift blame whenever possible. For General Motors, he goes on the media to shift the blame; instead of GM taking the blame for their non-deploying airbags and faulty power steering, Bass helps them blame those who died because of these issues. He claims that the victims were drunk or didn’t wear their seat belts properly.
Another large mistake that Kyle Bass has made is in line with pharmaceutical firms. He picks certain firms and short-sells their stocks. After that, he challenges them against the Coalition for Affordable Drugs, causing the stocks to go down. When the stocks go down, the prices go up. The bad part in this is that they have less to invest in medical research, which hurts millions of people. These people rely on these firms to help with their pain, but for Kyle Bass, it just rakes in money for himself.